Seoul Pharma Co., Ltd (KOSDAQ:018680)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,790.00
-55.00 (-1.93%)
At close: Apr 29, 2026
-17.21%
Market Cap 33.17B
Revenue (ttm) 52.15B
Net Income (ttm) 753.64M
Shares Out 11.66M
EPS (ttm) n/a
PE Ratio 44.01
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 46,754
Average Volume 10,051
Open 2,840.00
Previous Close 2,845.00
Day's Range 2,700.00 - 2,900.00
52-Week Range 2,310.00 - 4,205.00
Beta 0.50
RSI 47.48
Earnings Date n/a

About Seoul Pharma

Seoul Pharma Co., Ltd manufactures and sells pharmaceutical products in South Korea and internationally. The company offers orally disintegrating film products for therapeutic areas, including urology, neurology, nutrition, endocrinology, and OB/GY. Its products include VULTEUM and VULTIS for erectile dysfunction; ARTPEZIL for Alzheimer’ disease; OBCARE to treat overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency; and CH.V, as well as products for schizophrenia, vitamin supplement, obesity, tonic, and m... [Read more]

Industry Pharmaceutical Preparations
Founded 1976
Employees 172
Stock Exchange KOSDAQ
Ticker Symbol 018680
Full Company Profile

Financial Performance

In 2025, Seoul Pharma's revenue was 52.15 billion, a decrease of -2.67% compared to the previous year's 53.58 billion. Earnings were 753.64 million, a decrease of -55.63%.

Financial Statements

News

There is no news available yet.